176 related articles for article (PubMed ID: 26134050)
1. Biomarkers define distinct types of diffuse glioma.
Cancer Discov; 2015 Aug; 5(8):787. PubMed ID: 26134050
[TBL] [Abstract][Full Text] [Related]
2. Diffuse Midline Gliomas without the H3 K27M Mutation: Surgical Biopsy is Needed to Better our Diagnostic Understanding.
Lu VM; Raghunathan A; Schwartz JD; Daniels DJ
World Neurosurg; 2020 May; 137():472-473. PubMed ID: 32365434
[No Abstract] [Full Text] [Related]
3. [Diagnosis and prognosis of gliomas--current prospects of molecular diagnostics].
Haapasalo J; Hyartt A; Salmi M; Nordfors K; Lahtela SL; Kähkönen M; Helén P; Haapasalo H
Duodecim; 2014; 130(9):893-901. PubMed ID: 24881141
[TBL] [Abstract][Full Text] [Related]
4. Molecular diagnostics as a tool to personalize treatment in adult glioma patients.
Jeuken JW; van der Maazen RW; Wesseling P
Technol Cancer Res Treat; 2006 Jun; 5(3):215-29. PubMed ID: 16700618
[TBL] [Abstract][Full Text] [Related]
5. Input of molecular analysis in medical management of primary brain tumor patients.
Idbaih A; Duran-Peña A; Bonnet C; Ducray F
Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
[TBL] [Abstract][Full Text] [Related]
6. Progress in the application of molecular biomarkers in gliomas.
Wang J; Su HK; Zhao HF; Chen ZP; To SS
Biochem Biophys Res Commun; 2015 Sep; 465(1):1-4. PubMed ID: 26253473
[TBL] [Abstract][Full Text] [Related]
7. Tailored therapy in diffuse gliomas: using molecular classifiers to optimize clinical management.
Taylor JW; Chi AS; Cahill DP
Oncology (Williston Park); 2013 Jun; 27(6):504-14. PubMed ID: 23909061
[TBL] [Abstract][Full Text] [Related]
8. Updates in Pediatric Glioma Pathology.
Hakar MH; Wood MD
Surg Pathol Clin; 2020 Dec; 13(4):801-816. PubMed ID: 33183734
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNAs: potential molecular biomarkers for gliomas diagnosis and prognosis.
Wang L; Yu Z; Sun S; Peng J; Xiao R; Chen S; Zuo X; Cheng Q; Xia Y
Rev Neurosci; 2017 May; 28(4):375-380. PubMed ID: 28107175
[TBL] [Abstract][Full Text] [Related]
10. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs might be promising biomarkers of human gliomas.
Wang H; Yuan X; Zhou Z; Hu J; Zhang T; Hu S; Luo J; Li X
Asian Pac J Cancer Prev; 2011; 12(4):833-5. PubMed ID: 21790212
[TBL] [Abstract][Full Text] [Related]
12. Molecular characteristics of diffuse lower grade gliomas: what neurosurgeons need to know.
Young JS; Gogos AJ; Morshed RA; Hervey-Jumper SL; Berger MS
Acta Neurochir (Wien); 2020 Aug; 162(8):1929-1939. PubMed ID: 32472378
[TBL] [Abstract][Full Text] [Related]
13. The molecular biology of WHO grade II gliomas.
Marko NF; Weil RJ
Neurosurg Focus; 2013 Feb; 34(2):E1. PubMed ID: 23373446
[TBL] [Abstract][Full Text] [Related]
14. [Clinico-pathological and molecular aspects of diagnostic and prognostic value in gliomas].
Ortega-Aznar A; Jimenez-Leon P; Martinez E; Romero-Vidal FJ
Rev Neurol; 2013 Feb; 56(3):161-70. PubMed ID: 23359078
[TBL] [Abstract][Full Text] [Related]
15. Review of low-grade gliomas in children--evolving molecular era and therapeutic insights.
Khatua S; Wang J; Rajaram V
Childs Nerv Syst; 2015 May; 31(5):643-52. PubMed ID: 25722047
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers.
Jansen M; Yip S; Louis DN
Lancet Neurol; 2010 Jul; 9(7):717-26. PubMed ID: 20610347
[TBL] [Abstract][Full Text] [Related]
17. A distinctive pediatric case of low-grade glioma with extensive expression of CD34.
Nagaishi M; Yokoo H; Nobusawa S; Fujii Y; Sugiura Y; Suzuki R; Tanaka Y; Suzuki K; Hyodo A
Brain Tumor Pathol; 2016 Jan; 33(1):71-4. PubMed ID: 26496909
[No Abstract] [Full Text] [Related]
18. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
19. [Occurrence and molecular pathology of low grade gliomas].
Murnyák B; Csonka T; Klekner A; Hortobágyi T
Ideggyogy Sz; 2013 Sep; 66(9-10):305-11. PubMed ID: 24358685
[TBL] [Abstract][Full Text] [Related]
20. Biology and treatment of gliomas.
Janus TJ; Kyritsis AP; Forman AD; Levin VA
Ann Oncol; 1992 Jun; 3(6):423-33. PubMed ID: 1498059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
